Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | TJ Wickham, J Reynolds, DC Drummond, DB Kirpotin, J Lahdenranta, SC Leonard, E Geretti, H Lee, S Klinz, BS Hendriks, K Olivier, I Eckelhofer, JW Park, CC Benz, VM Moyo, C Niyikiza, and UB. Nielsen | ||||||||||||
Title | Abstract P3-14-09: Preclinical Safety and Activity of MM-302, a HER2-Targeted Liposomal Doxorubicin Designed To Have an Improved Safety and Efficacy Profile over Approved Anthracyclines | ||||||||||||
|
|||||||||||||
URL | http://cancerres.aacrjournals.org/content/70/24_Supplement/P3-14-09 | ||||||||||||
Abstract Text | Cancer Res December 15, 2010 70; P3-14-09 |
Molecular Profile | Treatment Approach |
---|
Gene Name | Source | Synonyms | Protein Domains | Gene Description | Gene Role |
---|
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|
Gene | Variant | Impact | Protein Effect | Variant Description | Associated with drug Resistance |
---|
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|